We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.2B
AUM Growth
-$235M
Cap. Flow
-$283M
Cap. Flow %
-1.55%
Top 10 Hldgs %
32.02%
Holding
333
New
17
Increased
37
Reduced
36
Closed
22

Sector Composition

Rank Sector Weight
1 Healthcare 28.16%
2 Technology 19.07%
3 Financials 13.73%
4 Industrials 8.28%
5 Communication Services 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMGA
176
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
$3.51M 0.02%
350,000
UTAA
177
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
$3.45M 0.02%
344,100
ALVO icon
178
Alvotech
ALVO
$1.29B
$3.38M 0.02%
500,000
EXAI
179
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$3.28M 0.02%
+400,000
New +$4.03M
SPCM
180
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$3.06M 0.02%
300,000
BCSA
181
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
$3.03M 0.02%
300,000
LBPH
182
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$3.02M 0.02%
810,500
LGV
183
DELISTED
Longview Acquisition Corp. II
LGV
$2.99M 0.02%
304,698
LGAC
184
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$2.98M 0.02%
300,000
SCLE
185
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
$2.46M 0.01%
250,000
HIII
186
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$2.46M 0.01%
250,000
LOKM
187
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$2.46M 0.01%
250,000
VTYX
188
DELISTED
Ventyx Biosciences
VTYX
$2.44M 0.01%
70,000
-860,648
-92% -$19.1M
LMACA
189
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$2.09M 0.01%
210,000
ANAC
190
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$1.98M 0.01%
200,000
BTTX
191
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$1.76M 0.01%
1,000,000
CLVR
192
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$1.49M 0.01%
82,230
BHVN icon
193
Biohaven
BHVN
$2.21B
$1.48M 0.01%
+240,405
New +$1.74M
AEON icon
194
AEON Biopharma
AEON
$13.5M
$1.48M 0.01%
2,083
THRX
195
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$1.29M 0.01%
223,149
-186,568
-46% -$1.32M
TMAC
196
DELISTED
The Music Acquisition Corporation
TMAC
$1.23M 0.01%
125,000
TNGX icon
197
Tango Therapeutics
TNGX
$4.41B
$1.09M 0.01%
300,000
DAOO
198
DELISTED
Crypto 1 Acquisition Corp Class A Ordinary Shares
DAOO
$1M 0.01%
100,000
NSTC
199
DELISTED
Northern Star Investment Corp. III
NSTC
$985K 0.01%
100,000
NSTD
200
DELISTED
Northern Star Investment Corp. IV
NSTD
$983K 0.01%
100,000

Similar funds

Farallon Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Farallon Capital Management held 333 positions worth $18.2B, down 1.3% from $18.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management's Q3 2022 filing shows 17 new, 37 increased, 36 reduced and 22 closed positions. Its largest new stake was Humana: 251,200 shares worth $122M. The largest sale was Coherent Inc, an estimated $154M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q3 2022 buy was Humana: 251,200 shares worth $122M.
  • Farallon Capital Management added most to ZENDESK INC in Q3 2022, an estimated $262M increase.
  • Farallon Capital Management's biggest Q3 2022 reduction was Howmet Aerospace, cutting an estimated $140M.
  • Farallon Capital Management fully exited Coherent Inc in Q3 2022, selling an estimated $154M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $18.2B portfolio in Q3 2022.
  • Farallon Capital Management opened 17 new positions and closed 22 in Q3 2022.
  • Farallon Capital Management's portfolio value fell 1.3% quarter-over-quarter to $18.2B.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.